Javascript must be enabled to continue!
Intensive care unit-acquired Stenotrophomonas maltophilia: incidence, risk factors, and outcome
View through CrossRef
Abstract
Introduction
The aim of this study was to determine incidence, risk factors, and impact on outcome of intensive care unit (ICU)-acquired Stenotrophomonas maltophilia.
Methods
This prospective observational case-control study, which was a part of a cohort study, was conducted in a 30-bed ICU during a three year period. All immunocompetent patients hospitalised >48 hours were eligible. Patients with non-fermenting Gram-negative bacilli (NF-GNB) at ICU admission were excluded. Patients without ICU-acquired S. maltophilia who developed an ICU-acquired NF-GNB other than S. maltophilia were also excluded. Screening (tracheal aspirate and skin, anal, and nasal swabs) for NF-GNB was performed in all patients at ICU admission and weekly. Univariate and multivariate analyses were performed to determine risk factors for ICU-acquired S. maltophilia and for ICU mortality.
Results
Thirty-eight (2%) patients developed an S. maltophilia ICU-acquired colonisation and/or infection and were all successfully matched with 76 controls. Chronic obstructive pulmonary disease (COPD) and duration of antibiotic treatment (odds ratio [OR] [95% confidence interval (CI)] = 9.4 [3 to 29], p < 0.001, and 1.4 [1 to 2.3], p = 0.001, respectively) were independently associated with ICU-acquired S. maltophilia. Mortality rate (60% versus 40%, OR [95% CI] = 1.3 [1 to 1.7, p = 0.037]), duration of mechanical ventilation (23 ± 16 versus 7 ± 11 days, p < 0.001), and duration of ICU stay (29 ± 21 versus 15 ± 17 days, p < 0.001) were significantly higher in cases than in controls. In addition, ICU-acquired infection related to S. maltophilia was independently associated with ICU mortality (OR [95% CI] = 2.8 [1 to 7.7], p = 0.044).
Conclusion
COPD and duration of antibiotic treatment are independent risk factors for ICU-acquired S. maltophilia. ICU-acquired S. maltophilia is associated with increased morbidity and mortality rates. ICU-acquired infection related to S. maltophilia is an independent risk factor for ICU mortality.
Springer Science and Business Media LLC
Title: Intensive care unit-acquired Stenotrophomonas maltophilia: incidence, risk factors, and outcome
Description:
Abstract
Introduction
The aim of this study was to determine incidence, risk factors, and impact on outcome of intensive care unit (ICU)-acquired Stenotrophomonas maltophilia.
Methods
This prospective observational case-control study, which was a part of a cohort study, was conducted in a 30-bed ICU during a three year period.
All immunocompetent patients hospitalised >48 hours were eligible.
Patients with non-fermenting Gram-negative bacilli (NF-GNB) at ICU admission were excluded.
Patients without ICU-acquired S.
maltophilia who developed an ICU-acquired NF-GNB other than S.
maltophilia were also excluded.
Screening (tracheal aspirate and skin, anal, and nasal swabs) for NF-GNB was performed in all patients at ICU admission and weekly.
Univariate and multivariate analyses were performed to determine risk factors for ICU-acquired S.
maltophilia and for ICU mortality.
Results
Thirty-eight (2%) patients developed an S.
maltophilia ICU-acquired colonisation and/or infection and were all successfully matched with 76 controls.
Chronic obstructive pulmonary disease (COPD) and duration of antibiotic treatment (odds ratio [OR] [95% confidence interval (CI)] = 9.
4 [3 to 29], p < 0.
001, and 1.
4 [1 to 2.
3], p = 0.
001, respectively) were independently associated with ICU-acquired S.
maltophilia.
Mortality rate (60% versus 40%, OR [95% CI] = 1.
3 [1 to 1.
7, p = 0.
037]), duration of mechanical ventilation (23 ± 16 versus 7 ± 11 days, p < 0.
001), and duration of ICU stay (29 ± 21 versus 15 ± 17 days, p < 0.
001) were significantly higher in cases than in controls.
In addition, ICU-acquired infection related to S.
maltophilia was independently associated with ICU mortality (OR [95% CI] = 2.
8 [1 to 7.
7], p = 0.
044).
Conclusion
COPD and duration of antibiotic treatment are independent risk factors for ICU-acquired S.
maltophilia.
ICU-acquired S.
maltophilia is associated with increased morbidity and mortality rates.
ICU-acquired infection related to S.
maltophilia is an independent risk factor for ICU mortality.
Related Results
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...
2674. Microbiome and Cumulative Antibiotic Use as Predictors of Stenotrophomonas maltophilia Infection in Patients with Acute Myeloid Leukemia Receiving Remission-Induction Chemotherapy
2674. Microbiome and Cumulative Antibiotic Use as Predictors of Stenotrophomonas maltophilia Infection in Patients with Acute Myeloid Leukemia Receiving Remission-Induction Chemotherapy
Abstract
Background
S. maltophilia infections are increasingly common in patients with acute myeloid leukemia (AML) and associat...
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract
Introduction
Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
Stenotrophomonas oleivorans sp. nov.
A polycyclic aromatic hydrocarbon-degrading strain isolated from crude oil contaminated soil
Stenotrophomonas oleivorans sp. nov.
A polycyclic aromatic hydrocarbon-degrading strain isolated from crude oil contaminated soil
Abstract
ASS1 was isolated as a motile Stenotrophomonas strain from crude oil-contaminated soils in Tabasco, Mexico. We characterized this strain...
Outcomes of Stenotrophomonas maltophilia hospital-acquired pneumonia in intensive care unit: a nationwide retrospective study
Outcomes of Stenotrophomonas maltophilia hospital-acquired pneumonia in intensive care unit: a nationwide retrospective study
Abstract
Background
There is little descriptive data on Stenotrophomonas maltophilia hospital-acquired pneumonia (HAP) in critically ill patients. T...
Prevalência e resistência a antibióticos de Stenotrophomonas maltophilia em amostras clínicas: estudo epidemiológico de 10 anos
Prevalência e resistência a antibióticos de Stenotrophomonas maltophilia em amostras clínicas: estudo epidemiológico de 10 anos
Introdução: Stenotrophomonas maltophilia é um patógeno oportunista emergente, associado, principalmente, a infecções nosocomiais. As opções terapêuticas para o tratamento de infecç...
Genotypic Diversity, Antibiotic Resistance, and Virulence Phenotypes of Stenotrophomonas maltophilia Clinical Isolates from a Thai University Hospital Setting
Genotypic Diversity, Antibiotic Resistance, and Virulence Phenotypes of Stenotrophomonas maltophilia Clinical Isolates from a Thai University Hospital Setting
Stenotrophomonas maltophilia is a multidrug-resistant organism that is emerging as an important opportunistic pathogen. Despite this, information on the epidemiology and characteri...
1235. Roles of Tetracyclines for Treatment of Stenotrophomonas maltophilia Pneumonia
1235. Roles of Tetracyclines for Treatment of Stenotrophomonas maltophilia Pneumonia
Abstract
Background
Stenotrophomonas maltophilia is a multidrug resistant organism with limited antibiotic treatment options. Su...

